2-TIP QANDLI DIABET RIVOJLANISHIDA INSULIN REZISTENTLIGINING ROLI VA ZAMONAVIY DAVOLASH USULLARI
Keywords:
2-tip qandli diabet, insulin rezistentligi, glyukoza almashinuvi, metformin, SGLT2 ingibitorlari, GLP-1 agonistlari, metabolik sindrom, semizlik.Abstract
Mazkur ilmiy maqolada 2-tip qandli diabet rivojlanishida insulin rezistentligining patofiziologik mexanizmlari, uning metabolik buzilishlar bilan o‘zaro bog‘liqligi hamda kasallikni davolashda qo‘llanilayotgan zamonaviy yondashuvlar tahlil qilinadi. Insulin rezistentligi organizm hujayralarining insulin gormoniga sezuvchanligining pasayishi bilan tavsiflanadi va u glyukoza almashinuvi buzilishining asosiy omillaridan biri hisoblanadi. Tadqiqotlarda insulin rezistentligi semizlik, yallig‘lanish jarayonlari, genetik omillar va turmush tarzi bilan chambarchas bog‘liq ekanligi aniqlangan. Maqolada metformin, SGLT2 ingibitorlari, GLP-1 retseptor agonistlari kabi zamonaviy farmakologik vositalarning samaradorligi ham ilmiy manbalar asosida tahlil qilinadi.
References
International Diabetes Federation. IDF Diabetes Atlas. – Brussels: IDF, 2021. – 15–22-betlar.
DeFronzo R.A. Insulin resistance and diabetes. – Diabetes Care, 2009. – 173–180-betlar.
Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose metabolism. – Nature, 2001. – 799–806-betlar.
American Diabetes Association. Standards of Medical Care in Diabetes. – Diabetes Care, 2023. – 45–52-betlar.
World Health Organization. Global report on diabetes. – Geneva: WHO, 2016. – 30–41-betlar.
Shulman G.I. Cellular mechanisms of insulin resistance. – Journal of Clinical Investigation, 2000. – 171–176-betlar.
Kahn S.E., Hull R.L. Mechanisms linking obesity to insulin resistance. – Nature, 2006. – 840–846-betlar.
Taylor R. Pathogenesis of type 2 diabetes. – Lancet Diabetes & Endocrinology, 2013. – 149–156-betlar.
Rena G., Hardie D.G. The mechanisms of action of metformin. – Diabetologia, 2017. – 1577–1585-betlar.
Zinman B. et al. Empagliflozin cardiovascular outcomes trial. – New England Journal of Medicine, 2015. – 2117–2128-betlar.
Drucker D.J. Mechanisms of action of GLP-1 receptor agonists. – Cell Metabolism, 2018. – 740–756-betlar.
Wild S. Global prevalence of diabetes. – Diabetes Care, 2004. – 1047–1053-betlar.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo